Therefore, inducing ICD in tumor cells, reducing PD-L1 protein expression and cancer stem cells are beneficial to activate and restore anti-tumor immunity, control cancer cell metastasis and overcome drug resistance. This evidence concerns the gene CD274 and neoplasm.